Australian company Anatara Lifesciences (ASX:ANR) has updated investors on the GaRP-Irritable Bowel Syndrome phase 2 trial and the anti-obesity project. …
Anatara Lifesciences updates on GaRP-Irritable Bowel Syndrome trial
March 10, 2025 Australian Biotech
Latest Video
New Stories
-
Anatara Lifesciences updates on GaRP-Irritable Bowel Syndrome trial
March 10, 2025 - - Australian Biotech -
Kidney Health Australia urges those at risk to get checked
March 10, 2025 - - Other Health -
Discouraging treatment because of carbon emissions should be based on facts
March 10, 2025 - - Latest News -
Is anybody really interested in bold, once-in-a-generation reform?
March 10, 2025 - - Latest News -
Sanofi announces new vaccine medical ahead for Australia, NZ and South Korea
March 10, 2025 - - Latest News -
Public summary document shows slow progress on weight loss therapy
March 8, 2025 - - Latest News -
The 'Dispatched' week in review podcast - 7 March
March 7, 2025 - - Podcast